cell and gene therapies

“This past year we've seen FDA and CBER leaders drum up plans to make a big push on assessing new cell and gene therapies, as well as introducing new guidance on accelerated approvals for these new areas of product development.”

“If we're gonna make this widely accessible to patients that need them, it's gonna have to be affordable. So we'll need new models for how pharmaceutical companies charge for this, and we're seeing early days of this. We're going to need new models for how paye…”

“There are dozens of drugs of this ilk that are projected to be approved and brought onto the market in the next several years”

“Some of these cell and gene therapies that I mentioned can, it can be a one-time cost of, you know, two to three million dollars, and sometimes more.”